Pfizer is making headlines with its $7.3 billion acquisition of Metsera, a weight loss drugmaker, as it aims to capture a share of the booming obesity drug market. This deal highlights the growing demand for innovative obesity treatments and Pfizer's strategic pivot following setbacks in its own drug pipeline.
A new UNICEF report reveals that childhood obesity has surpassed underweight cases globally for the first time, with alarming rates of overweight children. Discover the causes and potential solutions to this growing health crisis.
A groundbreaking study by UNICEF reveals that for the first time, more children worldwide are obese than underweight, with 188 million affected. The shift to ultra-processed diets is alarming, prompting calls for healthier policies.
A UN report reveals a troubling shift in childhood nutrition, with obesity now affecting more children than underweight status. The rise of ultra-processed foods poses serious health risks, prompting urgent calls for action.
The World Health Organization has released its updated Essential Medicines Lists, adding crucial cancer and diabetes treatments, aiming to improve global health access.
Lilly's new oral pill, Orforglipron, has shown promising results in reducing weight and improving blood sugar levels in diabetes patients. With nearly 4% rise in shares, the drug is on track for FDA approval.
Eli Lilly's new obesity pill, orforglipron, faces tough competition but could disrupt the weight loss market. Despite underwhelming trial results, analysts see potential for success due to manufacturing advantages and pricing strategies.
Discover how a daily 15-minute brisk walk can significantly improve heart health and reduce mortality risk, proving that pace matters more than paces. This study emphasizes the importance of brisk walking for all ages.
Are you one of the many Americans using GLP-1 drugs like Ozempic or Wegovy? Discover essential lifestyle tips to prevent nutrient deficiencies and muscle loss while maximizing your weight loss results!
Coca-Cola responds to Trump's claims about switching to cane sugar, defending its use of corn syrup and addressing health concerns related to obesity. The debate raises questions about the future of soft drinks in the U.S.
